<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: viral proteins</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Prediction of seasonal flu strains improves chances of universal vaccine</title>
   	 <description>(Medical Xpress)—Researchers have determined a way to predict and protect against new strains of the flu virus, in the hope of improving immunity against the disease.</description>
	  <link>http://medicalxpress.com/news/2013-03-seasonal-flu-strains-chances-universal.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 12 Mar 2013 08:15:54 EST</pubDate>
	 <guid isPermaLink="false">news282294946</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/predictionof.jpg" width="90" height="91" />
</item>
<item>
     <title>Promising new method for next-generation live-attenuated viral vaccines against Chikungunya virus</title>
   	 <description>Researchers have successfully applied a novel method of vaccine creation for Chikungunya virus (CHIKV) using a technique called large scale random codon re-encoding. Using this approach, a group from the UMR_D 190, Emerging viruses Department in Marseille, France in collaboration with the University of Sydney, Australia, demonstrated that the engineered viruses exhibit a stable phenotype with a significantly decreased viral fitness (i.e., replication capacity), making it a new vaccine candidate for this emerging viral disease. This new report publishes on February 21 in the Open Access journal, PLOS Pathogens.</description>
	  <link>http://medicalxpress.com/news/2013-02-method-next-generation-live-attenuated-viral-vaccines.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 21 Feb 2013 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news280685328</guid>
	 
</item>
<item>
     <title>Cervical cancer: First 3-D image of an HPV oncoprotein</title>
   	 <description>(Medical Xpress)—For the first time, researchers from the Laboratoire biotechnologie et signalisation cellulaire at the Strasbourg-based Ecole supérieure de biotechnologie (CNRS/Université de Strasbourg) and Institut de génétique et de biologie moléculaire et cellulaire (CNRS/Université de Strasbourg/Inserm) have solved the three-dimensional structure of an important oncoprotein involved in cell proliferation and in the development of the human papilloma virus (HPV). Type 16 (HPV 16), which causes cervical cancer, is the most dangerous of human papilloma viruses. This work, published in Science on 8 February 2013, should make it possible to identify and improve medication to block the protein and prevent it from causing tumors.</description>
	  <link>http://medicalxpress.com/news/2013-02-cervical-cancer-d-image-hpv.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 15 Feb 2013 09:40:02 EST</pubDate>
	 <guid isPermaLink="false">news280142866</guid>
	 
</item>
<item>
     <title>HCMV researchers utilize novel techniques to show preferential repair of the viral genome</title>
   	 <description>A new study about Human Cytomegalovirus (HCMV), a leading cause of birth defects, reveals how the virus co-opts cells' abilities to repair themselves. In the paper published on November 29 in the Open Access journal PLOS Pathogens, O'Dowd et al. describe their utilization of a novel technique for the simultaneous evaluation of both the viral and host genomes in an infected cell.</description>
	  <link>http://medicalxpress.com/news/2012-11-hcmv-techniques-preferential-viral-genome.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 29 Nov 2012 17:39:20 EST</pubDate>
	 <guid isPermaLink="false">news273433147</guid>
	 
</item>
<item>
     <title>Researchers describe elusive replication machinery of flu viruses</title>
   	 <description>Scientists at The Scripps Research Institute (TSRI) have made a major advance in understanding how flu viruses replicate within infected cells. The researchers used cutting-edge molecular biology and electron-microscopy techniques to &quot;see&quot; one of influenza's essential protein complexes in unprecedented detail. The images generated in the study show flu virus proteins in the act of self-replication, highlighting the virus's vulnerabilities that are sure to be of interest to drug developers.</description>
	  <link>http://medicalxpress.com/news/2012-11-elusive-replication-machinery-flu-viruses.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 22 Nov 2012 14:00:13 EST</pubDate>
	 <guid isPermaLink="false">news272810332</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/ku76r76tdu.jpg" width="90" height="90" />
</item>
<item>
     <title>Discovery could lead to faster diagnosis for some chronic fatigue syndrome cases</title>
   	 <description>For the first time, researchers have landed on a potential diagnostic method to identify at least a subset of patients with chronic fatigue syndrome (CFS), a complex disorder with no known definitive cause or cure.</description>
	  <link>http://medicalxpress.com/news/2012-11-discovery-faster-diagnosis-chronic-fatigue.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 14 Nov 2012 18:10:01 EST</pubDate>
	 <guid isPermaLink="false">news272130099</guid>
	 
</item>
<item>
     <title>Discovery may shed light on why some HIV-positive patients have more virus</title>
   	 <description>(Medical Xpress)—Biologists at UC San Diego have unraveled the anti-viral mechanism of a human gene that may explain why some people infected with HIV have much higher amounts of virus in their bloodstreams than others.</description>
	  <link>http://medicalxpress.com/news/2012-09-discovery-hiv-positive-patients-virus.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Mon, 24 Sep 2012 07:10:48 EST</pubDate>
	 <guid isPermaLink="false">news267689428</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/3-discoverymay.jpg" width="90" height="90" />
</item>
<item>
     <title>Catching the cap-snatcher: Structural analysis opens the way to new anti-influenza drugs</title>
   	 <description>Researchers at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, have determined the detailed 3-dimensional structure of part of the flu virus' RNA polymerase, an enzyme that is crucial for influenza virus replication. This important finding is published today in PLoS Pathogens. The research was done on the 2009 pandemic influenza strain but it will help scientists to design innovative drugs against all the different influenza strains, and potentially lead to a new class of anti-flu drugs in the next 5-10 years.</description>
	  <link>http://medicalxpress.com/news/2012-08-cap-snatcher-analysis-anti-influenza-drugs.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 02 Aug 2012 17:47:19 EST</pubDate>
	 <guid isPermaLink="false">news263148430</guid>
	 
</item>
<item>
     <title>Animal model replicates human immune response against HIV, could revolutionize HIV vaccine research</title>
   	 <description>One of the challenges to HIV vaccine development has been the lack of an animal model that accurately reflects the human immune response to the virus and how the virus evolves to evade that response. In the July 18 issue of Science Translational Medicine, researchers from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard report that a model created by transplanting elements of the human immune system into an immunodeficient mouse addresses these key issues and has the potential to reduce significantly the time and costs required to test candidate vaccines.</description>
	  <link>http://medicalxpress.com/news/2012-07-animal-replicates-human-immune-response.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 18 Jul 2012 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news261824850</guid>
	 
</item>
<item>
     <title>Researchers develop and test new anti-cancer vaccine</title>
   	 <description>Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others. The research was published in a recent issue of Cancer Immunology, Immunotherapy.</description>
	  <link>http://medicalxpress.com/news/2012-06-anti-cancer-vaccine.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 08 Jun 2012 18:06:13 EST</pubDate>
	 <guid isPermaLink="false">news258397553</guid>
	 
</item>
<item>
     <title>Small molecular bodyguards kill HPV-infected cancer cells by protecting tumor-suppressor</title>
   	 <description>Researchers at The Wistar Institute announce the discovery of small molecules that kill cancer cells caused by infection with human papillomavirus (HPV). Their results, in both cell and mouse models, demonstrate that the small molecule inhibitors protect a tumor-suppressing protein targeted by viral proteins, thus killing the infected tumor cells.</description>
	  <link>http://medicalxpress.com/news/2012-04-small-molecular-bodyguards-hpv-infected-cancer.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 26 Apr 2012 13:12:08 EST</pubDate>
	 <guid isPermaLink="false">news254664654</guid>
	 
</item>
<item>
     <title>Researchers identify promising new drug target for kidney disease</title>
   	 <description>Researchers from Mount Sinai School of Medicine have identified a regulator protein that plays a crucial role in kidney fibrosis, a condition that leads to kidney failure. Finding this regulator provides a new therapeutic target for the millions of Americans affected by kidney failure. The research is published in the March 11 issue of Nature Medicine.</description>
	  <link>http://medicalxpress.com/news/2012-03-drug-kidney-disease.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 11 Mar 2012 14:00:18 EST</pubDate>
	 <guid isPermaLink="false">news250690864</guid>
	 
</item>
<item>
     <title>Annual childhood flu vaccines may interfere with development of crossresistance</title>
   	 <description>Vaccinating children annually against influenza virus interferes with their development of cross-reactive killer T cells to flu viruses generally, according to a paper in the November Journal of Virology.</description>
	  <link>http://medicalxpress.com/news/2011-11-annual-childhood-flu-vaccines-crossresistance.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 17 Nov 2011 09:50:02 EST</pubDate>
	 <guid isPermaLink="false">news240741182</guid>
	 
</item>
<item>
     <title>Novel strategy stymies SARS: Versatile inhibitor prevents viral replication</title>
   	 <description>Broad-spectrum antibiotics, which are active against a whole range of bacterial pathogens, have been on the market for a long time. Comparably versatile drugs to treat viral diseases, on the other hand, have remained elusive. Using a new approach, research teams led by Dr. Albrecht von Brunn of LMU Munich and Professor Christian Drosten from the University of Bonn have identified a compound that inhibits the replication of several different viruses, including the highly aggressive SARS virus that is responsible for severe acute respiratory syndrome.</description>
	  <link>http://medicalxpress.com/news/2011-10-strategy-stymies-sars-versatile-inhibitor.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 28 Oct 2011 13:03:28 EST</pubDate>
	 <guid isPermaLink="false">news239025794</guid>
	 
</item>
<item>
     <title>Natural killer cells contribute to immune response against HIV</title>
   	 <description>A new study shows for the first time that natural killer (NK) cells, which are part of the body's first-line defence against infection, can contribute to the immune response against HIV.  In an article in the August 4 issue of Nature, a research team based at the Ragon Institute of MGH, MIT and Harvard reports that the HIV strains infecting individuals with particular receptor molecules on their NK cells had variant forms of key viral proteins, implying that the virus had mutated to avoid NK cell activity.</description>
	  <link>http://medicalxpress.com/news/2011-08-natural-killer-cells-contribute-immune.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Wed, 03 Aug 2011 13:00:04 EST</pubDate>
	 <guid isPermaLink="false">news231594168</guid>
	 
</item>
<item>
     <title>FSU scientist leads research on AIDS-related cancer</title>
   	 <description>In the early days of the AIDS epidemic, a once-rare form of cancer known as Kaposi's sarcoma (KS) emerged as a frequent harbinger of HIV. Its stigma was best illustrated by Tom Hanks, who portrayed a gay man trying to conceal the cancerous skin lesions from his co-workers in the 1993 movie &quot;Philadelphia.&quot;</description>
	  <link>http://medicalxpress.com/news/2011-06-fsu-scientist-aids-related-cancer.html</link>
	 <category>HIV &amp; AIDS</category>
	 <pubDate>Fri, 03 Jun 2011 11:02:42 EST</pubDate>
	 <guid isPermaLink="false">news226317733</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/fsuscientist.jpg" width="90" height="90" />
</item>


</channel>
</rss>
